Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

NCT02301286 is registered in ClinicalTrials.gov with Leiden University as lead sponsor.

NCT NCT02301286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02301286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
Lead sponsor
Leiden University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 31, 2015
Completion date
December 31, 2027
Enrollment
770 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant therapy, colon cancer